Korean J Urol Oncol.  2020 Dec;18(3):170-182. 10.22465/kjuo.2020.18.3.170.

Expert Group Consensus Opinion on Prostate Cancer Diagnosis and Management in India: Part 1 of 2

Affiliations
  • 1Apollo Gleneagles Hospitals Limited, Kolkata, India
  • 2Department of Uro-Oncology, Siddhi Vinayak Ganapati Cancer Hospital, Miraj, India
  • 3Department of Urology, Muljibhai Patel Urological Hospital, Nadiad, Gujarat, India
  • 4Medical Affairs and Clinical Research, Ipca Laboratories Ltd., Mumbai, India

Abstract

Purpose
To evaluate Indian literature, clinical practice and develop consensus opinion on various aspects of prostate cancer diagnosis and management in order to assist medical practitioners across India in effectively choosing right treatment option for patients with prostate cancer.
Materials and Methods
At the CAP summit held in Kolkata on 2019, a group of leading experts from across India voted on 42 consensus statements. Final statements were derived on the basis of voting results and subsequent expert panel meeting. Based on the panellists discussion on various areas of prostate cancer and practicability of recommendation in clinical practice, 5 statements were deleted and a draft was prepared. The draft is divided into 2 parts; part 1 covers 16 statements on prostate cancer diagnosis and early prostate cancer.
Results
A total of 37 statements were accepted and finalised by expert panel members based on the voting results. Sixteen statements with varying degrees of support from the panel are described in detail in this article.
Conclusions
The statements derived from several Indian scientific evidences, local clinical experience, and international guidelines will serve as a reference guide for clinicians across India in the management of prostate cancer.

Keyword

Prostate cancer; Guideline; Prostate-specific antigen; Prostatectomy consensus
Full Text Links
  • KJUO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr